Evidence map›Paper›PMID 38898138›Full record

ArticleScientific reports2024

Recent daily life burdens associated with neovascular age-related macular degeneration involve difficulties in use of electronic devices.

Yoko Ozawa, Keisuke Yoshihara, Marwa Mezghani, Paulina Pierzchała, Mateusz Nikodem, Sylvaine Barbier, Mariko Nomoto, Yasuko Aitoku

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yoko OzawaDepartment of Clinical Regenerative Medicine, Fujita Medical Innovation Center Tokyo, 1-1-4, Hanedakuko, Ota-ku, Haneda Innovation City Zone A, Tokyo, 144-0041, Japan. ozawa@a5.keio.jp.ORCID 0000-0003-4797-5705
Keisuke YoshiharaBayer Yakuhin Ltd., Tokyo, Japan.
Marwa MezghaniPutnam Associates, Tunis, Tunisia.
Paulina PierzchałaPutnam Associates, Cracow, Poland.
Mateusz NikodemPutnam Associates, Cracow, Poland.
Sylvaine BarbierPutnam Associates, Lyon, France.
Mariko NomotoPutnam Associates, Tokyo, Japan.
Yasuko AitokuBayer Yakuhin Ltd., Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neovascular age-related macular degeneration (nAMD) is a prevalent cause of permanent vision loss and blindness in the elderly worldwide, with a significant impact on patients' daily lives. However, burdens related to nAMD from the patients' perspective have not been well documented. Here we developed a new questionnaire after eliciting nAMD patients' daily challenges followed by a pilot survey. Seven daily life burden domains were identified, and a quantitative survey was conducted using the questionnaire in the real-world clinic. Of the total 153 participants (mean age, 76.3 ± 8.3 years), 67 (43.8%) had bilateral nAMD, and 79 (52.7%) were classified into severe nAMD according to the best-corrected visual acuity with cut-off value of 0.52 in logMAR. Patients with bilateral and severe nAMD had significantly higher burden scores across all domains. Network models for the bilateral and severe disease subgroups identified the interactions between "activity of daily living" and "hand-eye coordination" and between "use of electronic devices" and "face recognition" domains, which were considered to be important burdens for the patients. These results can advance ophthalmologists' understanding of the impact of nAMD on patients' daily lives and the importance of active and continuing treatment for patients with nAMD.

Indexed as

Activities of Daily LivingMacular DegenerationAgedAged, 80 and overCost of IllnessFemaleHumansMaleQuality of LifeSurveys and QuestionnairesVisual AcuityAge-related macular degenerationBurden of diseaseElectronic deviceNetwork estimationPatient surveyQuestionnaire

Identifiers

PMID38898138
PMCPMC11187225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.